SSH - LONGVIEW INC. — History
CCN 452087 | 3-year financial timeline | COVID resilience: 24/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
-6.7%
Revenue CAGR (3yr)
-8.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $18M | $15M | -15.9% | -6.7% |
| Operating Expenses | $13M | $16M | $16M | +1.7% | +11.5% |
| Operating Margin | 24.0% | 10.3% | -8.4% | -181.7% | +0.0% |
| Net Income | $4M | $2M | $-1M | -168.7% | +0.0% |
| Licensed Beds | 32 | 32 | 32 | +0.0% | +0.0% |
| Total Patient Days | 8,793 | 9,074 | 8,262 | -8.9% | -3.1% |
| Medicare Day % | 59% | 53% | 56% | +5.8% | -3.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 24/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -12.9% ($17M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.7%
This Hospital
+7.6%
State Avg
Latest Margin
-8.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | -24.6% |
| FY2024 (proj) | $13M | -40.9% |
| FY2025 (proj) | $12M | -57.1% |